chr15-52407386-G-C

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_001382347.1(MYO5A):​c.852C>G​(p.Asn284Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000036 in 1,612,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

MYO5A
NM_001382347.1 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 0.653
Variant links:
Genes affected
MYO5A (HGNC:7602): (myosin VA) This gene is one of three myosin V heavy-chain genes, belonging to the myosin gene superfamily. Myosin V is a class of actin-based motor proteins involved in cytoplasmic vesicle transport and anchorage, spindle-pole alignment and mRNA translocation. The protein encoded by this gene is abundant in melanocytes and nerve cells. Mutations in this gene cause Griscelli syndrome type-1 (GS1) and neuroectodermal melanolysosomal disease, or Elejalde disease. [provided by RefSeq, Sep 2023]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.053923905).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000256 (39/152068) while in subpopulation AFR AF= 0.000942 (39/41400). AF 95% confidence interval is 0.000708. There are 0 homozygotes in gnomad4. There are 17 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO5ANM_001382347.1 linkc.852C>G p.Asn284Lys missense_variant Exon 8 of 42 ENST00000399233.7 NP_001369276.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO5AENST00000399233.7 linkc.852C>G p.Asn284Lys missense_variant Exon 8 of 42 5 NM_001382347.1 ENSP00000382179.4 Q9Y4I1-3F8WE88

Frequencies

GnomAD3 genomes
AF:
0.000256
AC:
39
AN:
152068
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000942
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000361
AC:
9
AN:
248984
Hom.:
0
AF XY:
0.0000296
AC XY:
4
AN XY:
135072
show subpopulations
Gnomad AFR exome
AF:
0.000517
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000130
AC:
19
AN:
1460704
Hom.:
0
Cov.:
30
AF XY:
0.00000826
AC XY:
6
AN XY:
726708
show subpopulations
Gnomad4 AFR exome
AF:
0.000508
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.000256
AC:
39
AN:
152068
Hom.:
0
Cov.:
32
AF XY:
0.000229
AC XY:
17
AN XY:
74268
show subpopulations
Gnomad4 AFR
AF:
0.000942
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000268
ESP6500AA
AF:
0.000263
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000414
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 13, 2015
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Uncertain:1
Oct 11, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.852C>G (p.N284K) alteration is located in exon 8 (coding exon 8) of the MYO5A gene. This alteration results from a C to G substitution at nucleotide position 852, causing the asparagine (N) at amino acid position 284 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Oct 17, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYO5A protein function. ClinVar contains an entry for this variant (Variation ID: 211574). This variant has not been reported in the literature in individuals affected with MYO5A-related conditions. This variant is present in population databases (rs370600193, gnomAD 0.07%). This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 284 of the MYO5A protein (p.Asn284Lys). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
14
DANN
Benign
0.76
DEOGEN2
Benign
0.21
T;.;T;T;.;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.96
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.76
T;T;T;T;T;T
M_CAP
Benign
0.075
D
MetaRNN
Benign
0.054
T;T;T;T;T;T
MetaSVM
Benign
-0.57
T
MutationAssessor
Benign
0.17
N;N;.;.;.;.
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.64
N;N;.;N;N;N
REVEL
Uncertain
0.30
Sift
Benign
0.43
T;T;.;T;T;T
Sift4G
Benign
0.46
T;T;T;T;T;T
Polyphen
0.0
B;B;.;.;.;.
Vest4
0.17
MutPred
0.57
Gain of methylation at N284 (P = 0.0038);Gain of methylation at N284 (P = 0.0038);Gain of methylation at N284 (P = 0.0038);Gain of methylation at N284 (P = 0.0038);Gain of methylation at N284 (P = 0.0038);Gain of methylation at N284 (P = 0.0038);
MVP
0.38
MPC
0.43
ClinPred
0.0077
T
GERP RS
1.5
Varity_R
0.048
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs370600193; hg19: chr15-52699583; API